Kaleido Biosciences Inc. (KLDO)
NASDAQ · Healthcare
Kaleido Biosciences Inc. Long Term Debt 2016–2021
Kaleido Biosciences Inc. annual long term debt history from 2016 to 2021. Long term debt refers to financial obligations that are due more than one year in the future.
- Kaleido Biosciences Inc. long term debt as of December 31, 2021: 5.5M, a 69.80% decrease year-over-year.
- Kaleido Biosciences Inc. long term debt for 2021 were 5.5M, a 69.80% decrease from 2020.
- Kaleido Biosciences Inc. long term debt for 2020 were 18.4M, a 9.89% decrease from 2019.
- Kaleido Biosciences Inc. long term debt for 2019 were 20.4M, a 37.49% increase from 2018.
- Kaleido Biosciences Inc. long term debt for 2018 were 14.8M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Kaleido Biosciences Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2021 | $6 |
| 2020 | $18 |
| 2019 | $20 |
| 2018 | $15 |
| 2017 | $15 |
| 2016 | $5 |
Kaleido Biosciences Inc. Long Term Debt — FAQ
Kaleido Biosciences Inc. (KLDO) long term debt over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KLDO's long term debt history?
The chart and table above show Kaleido Biosciences Inc.'s long term debt by year and by quarter, including the growth rate.